OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
Chatphatai Moonla, Darintr Sosothikul, Thita Chiasakul, et al.
Clinical and Applied Thrombosis/Hemostasis (2021) Vol. 27, pp. 107602962110089-107602962110089
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Anticoagulants for people hospitalised with COVID-19
Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, Jéssica Dantas de Sá Tinôco, et al.
Cochrane library (2022) Vol. 2022, Iss. 3
Open Access | Times Cited: 50

Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 8, Iss. 7, pp. 738-751
Open Access | Times Cited: 42

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
Toshiaki Iba, Jerrold H. Levy
Trends in Cardiovascular Medicine (2021) Vol. 32, Iss. 1, pp. 1-9
Open Access | Times Cited: 41

Systematic Ultrasound Screening for Lower Extremity Deep Vein Thrombosis in ICU Patients with Severe COVID-19: A Randomized Clinical Trial
Catherine De La Puente, David Flota Ruiz, Lluís Sánchez Besalduch, et al.
Journal of Intensive Care Medicine (2025)
Closed Access

A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
Dimitrios Velissaris, Christos Michailides, Iosif Karalis, et al.
The Anatolian Journal of Cardiology (2023), pp. 232-239
Open Access | Times Cited: 5

Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis
Hideto Yasuda, Takuya Mayumi, Hiromu Okano
Infection (2022) Vol. 50, Iss. 6, pp. 1453-1463
Open Access | Times Cited: 7

Anticoagulation in COVID-19: a review of current literature and guidelines
Bharat Narasimhan, Marta Lorente‐Ros, Jose S. Aguilar-Gallardo, et al.
Hospital Practice (2021) Vol. 49, Iss. 5, pp. 307-324
Closed Access | Times Cited: 9

3D-PAST: Risk Assessment Model for Predicting Venous Thromboembolism in COVID-19
Yi Lee, Qasim Jehangir, Chun‐Hui Lin, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 3949-3949
Open Access | Times Cited: 6

COVID-19 thromboprophylaxis. New evidence
Raquel Ferrandis, P. Sierra, A. Gómez‐Luque
Revista Española de Anestesiología y Reanimación (English Edition) (2023) Vol. 71, Iss. 1, pp. 34-47
Closed Access | Times Cited: 3

Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian Registry
Warley Cezar da Silveira, Lucas Emanuel Ferreira Ramos, Rafael Tavares Silva, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 7, pp. 1863-1878
Open Access | Times Cited: 5

Spotlight on Adenovirus-Based Vaccines and Rare Thrombotic Events
Salvatore Chirumbolo
Clinical and Applied Thrombosis/Hemostasis (2021) Vol. 27
Open Access | Times Cited: 3

Predictors of Venous Thromboembolism in COVID-19 Patients: Results of the COVID-19 Brazilian Registry
Warley Cezar da Silveira
Research Square (Research Square) (2022)
Closed Access | Times Cited: 2

Comparison of the Mortality and Bleeding Risk of Anticoagulant Doses in COVID-19 Patients: A Systematic Review and Meta-analysis
Athaya Febriantyo Purnomo, Mokhamad Fahmi Rizki Syaban, Icha Farihah Deniyati Faratisha, et al.
INDONESIAN JOURNAL OF PHARMACY (2022), pp. 186-192
Open Access | Times Cited: 2

Low molecular weight heparin is associated with better outcomes than unfractionated heparin for thromboprophylaxis in hospitalized COVID-19 patients: a meta-analysis
Mochamad Yusuf Alsagaff, Eka Prasetya Budi Mulia, Irma Maghfirah, et al.
European Heart Journal - Quality of Care and Clinical Outcomes (2022) Vol. 8, Iss. 8, pp. 909-918
Open Access | Times Cited: 2

Efficacy and Safety of Anticoagulants for COVID-19 Patients in the Intensive Care Unit: A Systematic Review and Meta-Analysis
Yulistiani Yulistiani, Vina Neldi, Budi Suprapti, et al.
Journal of Pharmacy & Pharmaceutical Sciences (2022) Vol. 25, pp. 274-284
Open Access | Times Cited: 2

Thromboembolism and Bleeding in COVID-19
Koray Durak
J — Multidisciplinary Scientific Journal (2021) Vol. 4, Iss. 3, pp. 476-485
Open Access | Times Cited: 1

Current Trend of Prescribing Anticoagulant and Antiviral Drugs in the Treatment of COVID- 19 Patients in a Corona Dedicated Hospital in Khulna
Muhammad Ashraful Kabir, Baishakhi Islam, Tasnim Rahman, et al.
Mediscope (2023) Vol. 10, Iss. 1, pp. 10-16
Open Access

Tromboprofilaxis en COVID-19. Nuevas evidencias
Raquel Ferrandis, P. Sierra, A. Gómez‐Luque
Revista Española de Anestesiología y Reanimación (2023) Vol. 71, Iss. 1, pp. 34-47
Closed Access

Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19
Keith Robinson, Laura L. Schott, T. G. Matthews, et al.
Clinical and Applied Thrombosis/Hemostasis (2022) Vol. 28
Open Access

COVID 19 E DOENÇAS CARDIOVASCULARES: AS CORRELAÇÕES PARA O AUMENTO DE MORBIMORTALIDADE
Laylla Ramos Leal Cerqueira, Kelli Costa Souza, Ankilma do Nascimento Andrade Feitosa, et al.
Revista interdisciplinar em saúde (2022) Vol. 9, Iss. Único, pp. 706-722
Open Access

Page 1 - Next Page

Scroll to top